Viridien
Short position disclosed on August 12, 2026.
5.32% of the capital sold short
7 disclosing funds
2,460 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 1.59% | +0.50 pt | July 31, 2026 | |
| Marshall Wace LLP | 0.80% | -0.39 pt | August 7, 2026 | |
| TWO Sigma Investments, LP | 0.64% | new | August 3, 2026 | |
| Citadel Advisors LLC | 0.61% | +0.01 pt | August 12, 2026 | |
| Walleye Capital LLC | 0.60% | new | August 7, 2026 | |
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | |
| Tudor Capital Europe LLP | 0.51% | new | May 7, 2026 |
On the other side: the funds that hold Viridien Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 7, 2023 | Qube Research & Technologies Limited | 1.28% | March 4, 2024 |
| November 7, 2023 | POINT72 Asset Management, L.P. | 0.49% | November 9, 2023 |
| November 6, 2023 | Marshall Wace LLP | 2.12% | March 24, 2025 |
| November 6, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 |
| November 3, 2023 | Marshall Wace LLP | 2.02% | March 24, 2025 |
| November 3, 2023 | Qube Research & Technologies Limited | 1.29% | March 4, 2024 |
| November 2, 2023 | Marshall Wace LLP | 1.94% | March 24, 2025 |
| November 1, 2023 | Qube Research & Technologies Limited | 1.46% | March 4, 2024 |
| October 31, 2023 | POINT72 Asset Management, L.P. | 0.59% | November 9, 2023 |
| October 30, 2023 | Marshall Wace LLP | 1.82% | March 24, 2025 |
| October 30, 2023 | Qube Research & Technologies Limited | 1.56% | March 4, 2024 |
| October 27, 2023 | Marshall Wace LLP | 1.76% | March 24, 2025 |
| October 27, 2023 | Qube Research & Technologies Limited | 1.62% | March 4, 2024 |
| October 26, 2023 | Qube Research & Technologies Limited | 1.72% | March 4, 2024 |
| October 25, 2023 | Marshall Wace LLP | 1.62% | March 24, 2025 |
| October 24, 2023 | Marshall Wace LLP | 1.53% | March 24, 2025 |
| October 23, 2023 | Qube Research & Technologies Limited | 1.81% | March 4, 2024 |
| October 23, 2023 | Marshall Wace LLP | 1.44% | March 24, 2025 |
| October 20, 2023 | Marshall Wace LLP | 1.34% | March 24, 2025 |
| October 20, 2023 | POINT72 Asset Management, L.P. | 0.69% | November 9, 2023 |
| October 19, 2023 | ActusRayPartners Limited | 0.50% | November 16, 2023 |
| October 18, 2023 | Qube Research & Technologies Limited | 1.75% | March 4, 2024 |
| October 17, 2023 | Marshall Wace LLP | 1.22% | March 24, 2025 |
| October 17, 2023 | ActusRayPartners Limited | 0.47% | October 19, 2023 |
| October 16, 2023 | Qube Research & Technologies Limited | 1.88% | March 4, 2024 |
| October 13, 2023 | Marshall Wace LLP | 1.13% | March 24, 2025 |
| October 12, 2023 | Qube Research & Technologies Limited | 1.97% | March 4, 2024 |
| October 12, 2023 | ActusRayPartners Limited | 0.51% | October 19, 2023 |
| October 11, 2023 | POINT72 Asset Management, L.P. | 0.78% | November 9, 2023 |
| October 10, 2023 | Qube Research & Technologies Limited | 2.01% | March 4, 2024 |
| October 6, 2023 | Marshall Wace LLP | 1.00% | March 24, 2025 |
| October 5, 2023 | Marshall Wace LLP | 0.95% | March 24, 2025 |
| October 3, 2023 | Qube Research & Technologies Limited | 1.90% | March 4, 2024 |
| October 3, 2023 | POINT72 Asset Management, L.P. | 0.88% | November 9, 2023 |
| October 2, 2023 | Qube Research & Technologies Limited | 1.82% | March 4, 2024 |
| October 2, 2023 | POINT72 Asset Management, L.P. | 0.90% | November 9, 2023 |
| September 28, 2023 | Qube Research & Technologies Limited | 1.76% | March 4, 2024 |
| September 26, 2023 | Qube Research & Technologies Limited | 1.60% | March 4, 2024 |
| September 26, 2023 | Marshall Wace LLP | 0.87% | March 24, 2025 |
| September 25, 2023 | Marshall Wace LLP | 0.91% | March 24, 2025 |
| September 22, 2023 | Qube Research & Technologies Limited | 1.53% | March 4, 2024 |
| September 22, 2023 | POINT72 Asset Management, L.P. | 0.82% | November 9, 2023 |
| September 21, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 |
| September 19, 2023 | POINT72 Asset Management, L.P. | 0.70% | November 9, 2023 |
| September 18, 2023 | Qube Research & Technologies Limited | 1.09% | March 4, 2024 |
| September 18, 2023 | Marshall Wace LLP | 0.82% | March 24, 2025 |
| September 18, 2023 | Citadel Advisors LLC | 0.47% | September 20, 2023 |
| September 15, 2023 | Qube Research & Technologies Limited | 1.28% | March 4, 2024 |
| September 15, 2023 | Marshall Wace LLP | 0.71% | March 24, 2025 |
| September 14, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
- Publicis Groupe SA 3.38% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at August 12, 2026, https://www.quivad.com/action/viridien?page=11